BLACKROCK GREATER EUROPE INVESTMENT TRUST plc
All information is at 30 April 2013 and unaudited.
Performance at month end with net income reinvested
One Three One Three Since launch
Month Months Year Years (20 Sep 04)
Net asset value* (Undiluted) 1.7% 3.1% 26.8% 32.4% 167.0%
Net asset value* (Diluted) 1.7% 3.1% 27.0% 32.4% 167.1%
Share price -0.6% 1.5% 26.3% 33.1% 154.7%
FTSE World Europe ex UK 2.6% 3.2% 28.1% 20.1% 109.2%
Sources: BlackRock and DataStream
At month end
Net asset value (capital only): 225.47p
Net asset value (including income): 229.41p
Net asset value (capital only)**: 225.47p
Net asset value (including income)**: 229.41p
Share price: 217.75p
Discount to NAV (including income): 5.1%
Discount to NAV (including income)**: 5.1%
Susbcriptionshare price 17.50p
Gearing: 3.9%
Net yield: 1.9%
Total assets (including income): £277.2m
Ordinary shares in issue: 116,285,355***
Subscription shares in issue 23,254,813
** Diluted for subscription shares.
*** Excluding 6,052,299 shares held in treasury.
Benchmark
Sector Analysis Total Assets (%) Index (%) Country Analysis Total Assets (%)
Consumer Goods 21.5 18.3 Switzerland 25.6
Financials 18.1 21.6 Germany 20.1
Health Care 16.6 12.6 France 18.3
Consumer Services 11.9 5.6 Netherlands 6.8
Basic Materials 11.8 8.6 Belgium 6.3
Industrials 8.0 13.7 Denmark 5.4
Technology 7.1 3.6 Russia 4.5
Oil & Gas 5.3 7.8 Ireland 3.5
Telecommunications 2.0 4.3 Finland 2.5
Utilities - 3.9 Portugal 2.4
Net current liabilities (2.3) - Spain 2.3
----- ----- Italy 2.0
100.0 100.0 Hungary 1.8
===== ===== Ukraine 0.8
Net current liabilities (2.3)
-----
100.0
=====
Ten Largest Equity Investments (in alphabetical order)
Company
Anheuser-Busch Belgium
Bayer Germany
Cie Financière Richemont Switzerland
Continental Germany
Novo Nordisk Denmark
Roche Switzerland
Sanofi France
SAP Germany
Swiss Re Switzerland
Zurich Insurance Switzerland
Commenting on the markets, Vincent Devlin, representing the Investment Manager
noted:
Market
During the month the Company's NAV rose by 1.7% and the share price fell by
0.6%. For reference, the FTSE World Europe ex UK Index gained 2.6% during the
same period.
The successful formation of the Italian government after 2 months of political
stalemate helped compress European equity risk premia and drive performance for
higher beta sectors and the periphery. Despite generally disappointing macro
releases (both from Europe itself and from key markets such as China), markets
continued to make progress. We continued to see inflows into European
equities.
The Company's underperformance in April when compared with the broader market
was mainly caused by the allocation of funds at a sector level. Telecoms,
utilities and financials all performed strongly in the market during the month,
and the Company's lower weightings in these sectors caused the portfolio to lag
in performance terms. From a stock perspective, holdings in consumer goods
were the least successful. In particular, holdings in German auto supplier
Continental and brewer Anheuser-Busch Inbev both underperformed during the
month.
Stock selection proved marginally more successful, especially within
industrials and health care. Within health care, holdings in defensive growth
names Novo Nordisk and Grifols both delivered solid returns. Within
industrials, avoiding conglomerates Siemens and Philips benefited the Fund as
the sector proved to be the worst performer during April.
At the end of the month, the Company had higher weightings (when compared to
the market) in consumer services, basic materials, consumer goods, technology
and health care and lower weightings in utilities, financials, telecoms,
industrials and oil & gas. The Company was also geared by around 5%.
Outlook
The resolution of the Italian political stalemate was well received by the
market, reducing equity risk premium and benefitting leveraged and peripheral
sectors which reacted most. At the same time, a global wall of accommodative
monetary policy has driven continued performance by equity markets, at the same
time as yields from other asset classes remain under pressure. The already
significant premium offered by European Equities over corporate bonds has
further increased and now stands at a decade long high.
While Q1 earnings results were mixed, the common theme was that companies with
a globally diverse customer base did better. Europe continues to be home to
global leaders, available at attractive valuations thanks to the domicile of
their listing as opposed to the customer base. However the political momentum
remains fragile and we therefore continue to focus on the long term winners and
high quality companies within the sector.
16 May 2013
ENDS
Latest information is available by typing www.brgeplc.co.uk on the internet,
"BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.